BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16572896)

  • 1. Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs.
    Pesic M; Markovic JZ; Jankovic D; Kanazir S; Markovic ID; Rakic L; Ruzdijic S
    J Chemother; 2006 Feb; 18(1):66-73. PubMed ID: 16572896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of the purine analog sulfinosine and curcumin on the multidrug resistant human non-small cell lung carcinoma cell line (NCI-H460/R).
    Andjelkovic T; Pesic M; Bankovic J; Tanic N; Markovic ID; Ruzdijic S
    Cancer Biol Ther; 2008 Jul; 7(7):1024-32. PubMed ID: 18414057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene amplification and expression in lung cancer cells with acquired paclitaxel resistance.
    Yabuki N; Sakata K; Yamasaki T; Terashima H; Mio T; Miyazaki Y; Fujii T; Kitada K
    Cancer Genet Cytogenet; 2007 Feb; 173(1):1-9. PubMed ID: 17284363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers.
    Chen YL; Yang TY; Chen KC; Wu CL; Hsu SL; Hsueh CM
    Cell Oncol (Dordr); 2016 Oct; 39(5):411-433. PubMed ID: 27306525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R).
    Pesić M; Andjelković T; Banković J; Marković ID; Rakić L; Ruzdijić S
    Invest New Drugs; 2009 Apr; 27(2):99-110. PubMed ID: 18493718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of cisplatin resistance in non-small cell lung cancer stem cells by Taxus chinensis var.
    Jiang YQ; Xu XP; Guo QM; Xu XC; Liu QY; An SH; Xu JL; Su F; Tai JB
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of a paclitaxel-resistant human non-small cell lung cancer cell line.
    Chu JJ; Chiang CD; Rao CS; Chang WM; Lai YK
    Anticancer Res; 2000; 20(4):2449-56. PubMed ID: 10953309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purine analogs sensitize the multidrug resistant cell line (NCI-H460/R) to doxorubicin and stimulate the cell growth inhibitory effect of verapamil.
    Pesić M; Podolski A; Rakić L; Ruzdijić S
    Invest New Drugs; 2010 Aug; 28(4):482-92. PubMed ID: 19533022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?
    Merk J; Rolff J; Dorn C; Leschber G; Fichtner I
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):e29-33. PubMed ID: 21420313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways.
    Wu SH; Hang LW; Yang JS; Chen HY; Lin HY; Chiang JH; Lu CC; Yang JL; Lai TY; Ko YC; Chung JG
    Anticancer Res; 2010 Jun; 30(6):2125-33. PubMed ID: 20651361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
    Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
    Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between the acquired multi-drug resistance of human large cell lung cancer cell line NCI-H460 by cisplatin selection and p53 mutation].
    Wang T; Xu J; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):102-7. PubMed ID: 15854392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
    Shinoda C; Maruyama M; Fujishita T; Dohkan J; Oda H; Shinoda K; Yamada T; Miyabayashi K; Hayashi R; Kawagishi Y; Fujita T; Matsui S; Sugiyama E; Muraguchi A; Kobayashi M
    Int J Cancer; 2005 Oct; 117(1):21-31. PubMed ID: 15880572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer.
    Bessho Y; Oguri T; Ozasa H; Uemura T; Sakamoto H; Miyazaki M; Maeno K; Sato S; Ueda R
    Oncol Rep; 2009 Jan; 21(1):263-8. PubMed ID: 19082471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of multidrug resistance-associated protein gene in non-small cell lung cancer].
    Xu M; Li J; Xia Q
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):268-70. PubMed ID: 11775850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of increased lung resistance protein expression with acquired etoposide resistance in human H460 lung cancer cell lines.
    Lee E; Lim SJ
    Arch Pharm Res; 2006 Nov; 29(11):1018-23. PubMed ID: 17146971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histology and sensitivity to anticancer drugs of two human non-small cell lung carcinomas implanted in the pleural cavity of nude mice.
    Kraus-Berthier L; Jan M; Guilbaud N; Naze M; Pierré A; Atassi G
    Clin Cancer Res; 2000 Jan; 6(1):297-304. PubMed ID: 10656461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing.
    Podolski-Renić A; Jadranin M; Stanković T; Banković J; Stojković S; Chiourea M; Aljančić I; Vajs V; Tešević V; Ruždijić S; Gagos S; Tanić N; Pešić M
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):683-97. PubMed ID: 23934261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.